Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DRAIC promotes growth of breast cancer by sponging miR-432-5p to upregulate SLBP
Sijie Li, Hongyao Jia, Zhiru Zhang, et al.
Cancer Gene Therapy (2021) Vol. 29, Iss. 7, pp. 951-960
Open Access | Times Cited: 19

Showing 19 citing articles:

Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancer
Chengdi Wang, Jingwei Li, Jingyao Chen, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Circ-TRIO promotes TNBC progression by regulating the miR-432-5p/CCDC58 axis
Zekun Wang, Yaming Li, H. J. Yang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 9
Open Access | Times Cited: 27
Multifaced roles of the long non-coding RNA DRAIC in cancer progression
Kouhei Sakurai, Hiroyasu Ito
Life Sciences (2024) Vol. 343, pp. 122544-122544
Closed Access | Times Cited: 5
Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients
Jinrong He, Dan Li, Qun-Xian Zhang, et al.
Aging (2023) Vol. 15, Iss. 22, pp. 13265-13286
Open Access | Times Cited: 7
The emerging potentials of lncRNA DRAIC in human cancers
Qinfan Yao, Xiuyuan Zhang, Dajin Chen
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
Cell-free circulating miRNAs-lncRNAs-mRNAs as predictive markers for breast cancer risk assessment in women exposed to indoor air pollution
Deeksha Agrawal, Roshani Kumari, Pooja Ratre, et al.
Case Studies in Chemical and Environmental Engineering (2022) Vol. 6, pp. 100267-100267
Open Access | Times Cited: 8
Functional Characterization of lncRNA152 as an Angiogenesis-Inhibiting Tumor Suppressor in Triple-Negative Breast Cancers
Dae-Seok Kim, Cristel V. Camacho, Rohit Setlem, et al.
Molecular Cancer Research (2022) Vol. 20, Iss. 11, pp. 1623-1635
Open Access | Times Cited: 7
The novel circFKBP8/miR-432-5p/E2F7 cascade functions as a regulatory network in breast cancer
Zhongkui Jin, Wang Xu, Kunlin Yu, et al.
Hereditas (2024) Vol. 161, Iss. 1
Open Access | Times Cited: 1
Circular RNAs in neuroblastoma: Pathogenesis, potential biomarker, and therapeutic target
Mohsen Karami Fath, Sasan Pourbagher Benam, Kiana Salmani, et al.
Pathology - Research and Practice (2022) Vol. 238, pp. 154094-154094
Closed Access | Times Cited: 6
Mitochondrial DNA methylation is a predictor of immunotherapy response and prognosis in breast cancer: scRNA-seq and bulk-seq data insights
Yixuan Ma, Juan Du, Meini Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Chromogenic in situ hybridization reveals specific expression pattern of long non-coding RNA DRAIC in formalin-fixed paraffin-embedded specimen
Kouhei Sakurai, Seiji Yamada, Rika Ito, et al.
Non-coding RNA Research (2023) Vol. 9, Iss. 1, pp. 76-83
Open Access | Times Cited: 3
KIAA1199 Correlates With Tumor Microenvironment and Immune Infiltration in Lung Adenocarcinoma as a Potential Prognostic Biomarker
Xiaoju Shen, Xiaocheng Mo, Weidan Tan, et al.
Pathology & Oncology Research (2022) Vol. 28
Open Access | Times Cited: 4
Has_circ_0000069 expression in breast cancer and its influences on prognosis and cellular activities
GANG WANG, MINGPING QIAN, WEI JIAN, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 1, pp. 63-70
Open Access | Times Cited: 2
Circular RNA ATP2C1 (has_circ_0005797) sponges miR-432/miR-335 to promote breast cancer progression through regulating CCND1 expression.
Caiping Chen, Jianju Lu, Wang Li, et al.
PubMed (2023) Vol. 13, Iss. 8, pp. 3433-3448
Closed Access | Times Cited: 2
LncRNA PART1 Regulates Ovarian Carcinoma Development via the miR-150-5p/MYB Axis
Jing Wang, Yun Han, Tingting Zhang, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 10
Open Access | Times Cited: 2
Acetyltransferase NAT10 promotes an immunosuppressive microenvironment by modulating CD8+ T cell activity in prostate cancer
Liu Ji, Zhuoran Gu, Libin Zou, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access
Integrated Analysis of Single-Cell RNA-seq and Bulk RNA-seq in the Identification of a Novel ceRNA Network and Key Biomarkers in Diabetic Kidney Disease
Yuejun Wang, Mingming Zhao, Yu Zhang
International Journal of General Medicine (2022) Vol. Volume 15, pp. 1985-2001
Open Access | Times Cited: 2
Prediction and screening of circRNA in triple-negative breast cancer.
Xuanhe Li, Song Zhang, Siyu Sun, et al.
PubMed (2022) Vol. 14, Iss. 11, pp. 8049-8063
Closed Access | Times Cited: 2
Functional Characterization oflncRNA152as an Angiogenesis-Inhibiting Tumor Suppressor in Triple-Negative Breast Cancers
Dae-Seok Kim, Shrikanth S. Gadad, Rohit Setlem, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top